- Open Access
Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender
© Pereira et al; licensee BioMed Central Ltd. 2010
- Received: 22 July 2010
- Accepted: 19 August 2010
- Published: 19 August 2010
Although advanced age is considered a risk factor for several diseases, the impact of gender on age-associated cardiovascular diseases, such as atherosclerotic processes and valvular diseases, remains not completely clarified. The present study was designed to assess aortic valve morphology and function and vascular damage in elderly using the apolipoprotein E knockout (ApoE KO) mouse. Our hypothesis was that advanced age-related cardiovascular changes are aggravated in atherosclerotic male mice.
The grade (0 to 4) of aortic regurgitation was evaluated through angiography. In addition, vascular lipid deposition and senescence were evaluated through histochemical analyses in aged male and female ApoE KO mice, and the results were compared to wild-type C57BL/6J (C57) mice.
Aortic regurgitation was observed in 92% of the male ApoE KO mice and 100% of the male C57 mice. Comparatively, in age-matched female ApoE KO and C57 mice, aortic regurgitation was observed in a proportion of 58% and 53%, respectively. Histological analysis of the aorta showed an outward (positive) remodeling in ApoE KO mice (female: 1.86 ± 0.15; male: 1.89 ± 0.68) using C57 groups as reference values. Histochemical evaluation of the aorta showed lipid deposition and vascular senescence only in the ApoE KO group, which were more pronounced in male mice.
The data show that male gender contributes to the progression of aortic regurgitation and that hypercholesterolemia and male gender additively contribute to the occurrence of lipid deposition and vascular senescence in elderly mice.
- Aortic Regurgitation
- Lipid Deposition
- Plasma Cholesterol Level
- Vascular Senescence
- Normal Chow Diet
Although several studies have characterized advanced age as a risk factor for cardiovascular diseases [1, 2], the impact of gender on age-associated cardiovascular performance remains to be completely delineated [3, 4]. This question is important because gender-related differences in cardiovascular aging, such as atherosclerotic processes and valvular diseases, may help to explain, in part, the greater longevity of females [5, 6].
Over the past few decades, the availability of new investigative tools, including the homozygous apolipoprotein E knockout (ApoE KO) mouse, has contributed to understanding the atherosclerotic process and cardiovascular diseases [7, 8]. ApoE is a constituent of VLDL synthesized by the liver, mediates high-affinity binding of ApoE containing lipoprotein particles to LDL receptors, and is responsible for the cellular uptake of these particles . Therefore, the ApoE KO mouse develops marked hypercholesterolemia and spontaneous atherosclerosis [9–11]. In this experimental model, the influence of gender has been reported only with Western-type cholesterol-rich diets in young adult mice [12, 13], but the impact of both elderly and gender on cardiovascular function has not been elucidated.
In the present study, our hypothesis was that advanced age affects the cardiovascular structure of atherosclerotic mice, which could be aggravated in males. On a normal chow diet, ApoE KO mice were subjected to in vivo angiography and to in vitro histochemical analysis to characterize valve and aortic morphology.
Aged male and female mice (18 months old) were randomly divided into four groups: C57 (females: n = 26; males: n = 22) and ApoE KO (females: n = 28; males: n = 23). Animals were obtained from the animal facilities of the Laboratory of Transgenes and Cardiovascular Control at the Federal University of Espirito Santo. Mice were fed a normal chow diet and water ad libitum and were housed separately in temperature-controlled rooms (22°C) under a 12 h light/dark cycle. All procedures were conducted in accordance with the institutional guidelines for animal research and the protocols were previously approved by the Institutional Ethics Committee for Use of Animals (CEUA 001/2009).
Mice were anesthetized with ketamine/xylazine (91.0/9.1 mg/kg, IP) and polyethylene catheters (PE10 - PE50) filled with heparinized (10 UI/mL) saline were inserted into the right carotid artery for the contrast agent infusion. Each mouse was placed in a supine position to obtain images at 0° and 45° with an angiographic X-ray System (Shimadzu Corporation, Japan) at a speed of 5 frames/s. The X-ray angiography was performed with a manual injector that was controlled to reproducibly deliver 0.15 mL/s of non-ionic contrast media containing 35% iodine (Telebrix; Guerbet, France) for 3 s. Serial images of each mouse were then recorded and the aorta internal diameter analyzed by quantitative coronary analysis software (QCA, Shimadzu Corporation, Japan). Detection of aortic regurgitation (AR) was evaluated by intensity, extension and persistence of contrast after successive systoles and classified by grades of severity (0 to 4) based on the study of Pujadas .
The wet weight of the lung was measured and the tissue was then placed in an oven at 60°C for 24 h. The lungs water content (%H2O) was determined as follows : %H2O = (wet weight - dry weight)/wet weight × 100. Cardiac wet weight was used to determine the cardiac weight/body weight ratio.
Histological Valve and Vessel Processing
At the end of the experiments, mice were euthanized with sodium thiopental overdose (100 mg/kg, IP) and perfused via the left ventricle with phosphate-buffered saline (PBS, pH 7.4; 0.1 M) followed by a fixative solution of formaldehyde (4%) at a pressure of 100 mmHg. After remaining overnight in the fixative solution, the perivascular adipose tissue of the aorta was removed. The aortic valve and the portion of the ascendant aorta were embedded in a 24% gelatin solution and then cross-sectioned at a 10-μm thickness using a cryostat (Jung CM1800; Leica, Wetzlar, Germany). For each animal, aorta cross-sections were mounted on gelatin-coated slides and stained with Oil-Red-O (Sigma-Aldrich, St. Louis, MO, USA) for neutral lipids detection and stained with hematoxylin (Sigma-Aldrich) for valve morphological analysis which was done by an independent investigator. Extreme care was taken in sectioning the heart so that the valves were cut transversely. For longitudinal analysis, the hearts were embedded in paraffin and cut on a longitudinal plane with sections of 8-12 μm thickness. The slides were stained with hematoxylin-eosin for detection of cellularity and thickness. The slides were also stained with Masson's trichrome for detection of the presence of fibrosis and with von Kossa for calcification analysis. The remnant whole aorta was opened lengthwise and stained en face for lipid deposition and vascular senescence activity.
Senescence Activity β-Gal Staining
Staining for senescence by β-gal activity was performed as described by Minamino et al. . Briefly, en face aortic samples were incubated for 24 h at 37°C in freshly prepared β-gal staining solutions (pH 6.0) containing 2.4 mM 5-bromo-4-chrolo-3-indlyl-D-galactopyranoside (X-gal, Sigma Aldrich), 4.7 mmol/L potassium ferrocyanide, 4.9 mmol/L potassium ferricyanide, 150 mmol/L NaCl, 1 mmol/L MgCl2 and 40 mmol/L citric acid. The senescence analysis was performed by detection of blue color produced by the enzymatic reaction and the images were captured with a photographic camera (Canon, USA). The quantification of senescence was performed using an National Institutes of Health (NIH) Image program (Image-J 1.35 d, NIH, Bethesda, USA) and the examiner was blinded to the experimental groups.
Images of the aorta and the valve were captured with a color video camera (VKC150, Hitachi, Tokyo, Japan) connected to a microscope (Olympus AX70, Olympus, Center Valley, PA, USA). Analysis was conducted with a Leica image program (2100 Leica EWS; Leica, Wetzlar, Germany) and an NIH Image program by an examiner blinded to the experimental groups. The program was calibrated with a graduated slide. By using a 4× objective, the vessel cross-sectional area (VCSA) and the lumen cross-sectional area were calculated. The vascular remodeling ratio was obtained by dividing each animal's VCSA by the average VCSA of the C57 group and each sample was classified as absence (0.95-1.05), inward (<0.95), or outward (>1.05) remodeling. In the left ventricle, the maximum thickness of the valvule and the width of at least 10 cardiomyocytes were measured for seven mice from each group.
Measurement of Plasma Cholesterol Levels
A blood sample (200 μL) was taken from the carotid artery of each animal and the plasma total cholesterol was measured using a commercial colorimetric kit (Bioclin, Belo Horizonte, Brazil).
Continuous variables are presented as mean ± SEM. Statistical analysis was performed with a one-way analysis of variance (ANOVA), followed by the Tukey post hoc test for multiple comparisons of continuous variables between groups. Student's t-test for independent samples was used when appropriate. Categorical variables are presented as frequencies and were compared using the Fisher's exact test. The significance level was set at p < 0.05.
Body and cardiac weight, cardiomyocyte size, pulmonary water content and plasma cholesterol levels of C57 and ApoE KO.
Body weight (g)
31 ± 0.9
33 ± 0.7
30 ± 0.5
32 ± 0.7
Cardiac weight/body weight ratio (mg/g)
5.9 ± 0.4
5.7 ± 0.4
6.0 ± 0.4
5.9 ± 0.3
Cardiomyocytes width (μm)
15 ± 0.1
15 ± 0.2
15 ± 0.1
15 ± 0.1
Pulmonary water content (%)
76 ± 0.6
76 ± 1.2
75 ± 0.5
76 ± 0.9
Plasma cholesterol (mg/dL)
81 ± 4
96 ± 7
336 ± 32*
650 ± 92# *
This study describes the functional and structural valvular and vascular changes by gender in normal and hypercholesterolemic aged mice. We observed that male gender is an important factor for the progression of aortic regurgitation in both normocholesterolemic (C57) and hypercholesterolemic (ApoE KO) mice. In addition to male gender, hypercholesterolemia also contributes to the occurrence of vascular senescence in elderly mice. In contrast, the outward (positive) remodeling observed in aortas of ApoE KO mice was not influenced by gender.
Diagnostic imaging methods used for investigating human cardiovascular diseases have also been used in rats  and with limitations in mice [8, 18]. While measuring the internal diameter of the aorta through angiography, we incidentally observed aortic regurgitation in elderly male mice. Age-related valvular changes and echocardiographic parameters have only been described in a few studies [19–21] but the influence of gender on those parameters was not investigated. To our knowledge, this study is the first to report a pronounced aortic regurgitation in aged male mice compared to age-matched females, independent of cholesterol levels. This finding does not appear to be due to estradiol protection as this result was also confirmed in ovariectomized females (data not shown). Moreover, we must consider that the observed sex differences may not simply be reflective of differences in levels of circulating hormones .
Aortic regurgitation results from malcoaptation of the aortic leaflets due to abnormalities . In our study, the observed aortic regurgitation was associated with an increase in valvular thickness. This has also been observed in other experimental rodent models [17, 19, 23] and humans . Although aortic regurgitation is a chronic disease characterized by cardiac volume overload that induces progressive cardiac hypertrophy and eventually contractile dysfunction [25, 26], neither compensatory cardiac hypertrophy nor pulmonary water content were observed. This finding is in agreement with studies done in humans showing that aortic regurgitation often remains asymptomatic for decades before the development of heart failure [17, 27]. It has also been shown that valvular regurgitation could be influenced by the type of anesthetic used, due to an effect on left ventricular ejection [28, 29]. In this study we used a ketamine and xylazine mixture, the most commonly used anesthetic during image analysis in mice [28, 30]. Although it has been described that this anesthetic could influence aortic regurgitation by reducing heart rate [19, 23], in our study, males and females had similar chronotropic activity after the catheterization procedure.
Valvulopathy usually occurs mainly in left-sided valves, particularly the aortic valve, which could be sequentially due to mechanical stress, cusp thickening, inflammation and decrease of cusp pliability, leading to regurgitation . In agreement with the above study, we also observed cusp thickening, collagen deposition, acellularity and aortic regurgitation in aged male mice of both groups. In addition, the influence of both gender and hypercholesterolemia on valvular lesions has been reported only in epidemiological studies [6, 32]. Our data show, for the first time, that male gender and hypercholesterolemia additively contribute to valvular degeneration without aggravation of aortic regurgitation.
In our study, the angiography also revealed the maintenance of aorta internal diameter in both C57 and ApoE KO groups. Ex vivo analysis confirmed this finding and showed an aorta outward remodeling. The vascular remodeling of large arteries is considered an adaptive structural change observed in both clinical [33–35] and experimental [7, 34, 36] studies in response to a variety conditions, such as atherosclerosis, hypertension and lumen obstruction. Aortic remodeling in ApoE KO mice is not established in young animals [7, 37] but is detected by 13 months of age . In our study, we observed that 18-month-old ApoE KO mice still preserve the aortic vessel lumen compared with normal animals (C57). Because overcompensation is a feature of the remodeling response in human coronary arteries , we suggest, as have others [33, 40], that the elderly ApoE KO mouse constitutes a good model for studies on advanced stages of remodeling mechanism of large arteries.
Even though aortic remodeling was found to be similar for both genders in ApoE KO mice, vascular senescence and lipid deposition were influenced by male gender. Senescent cells show progressive telomere shortening , negative gene expression regulators , decreased expression of vasodilators [43, 44] and increased proinflammatory molecules , contributing to both progression of atherosclerosis and pathogenesis of vascular aging [45, 46]. In this study, we evaluated senescence through β-gal activity, which is considered to be one of the best markers currently available. In agreement with other studies [41, 42], we observed that hypercholesterolemia promotes inflammation and vascular senescence. The novelty in this study is the finding that male gender and hypercholesterolemia have additive effects on vascular senescence and vessel lipid deposition. Although estrogens seem to slow the senescence through activation of estrogen receptors [22, 47], ovariectomy did not cause vascular senescence in C57 female mice and did not aggravate it in ApoE KO females (data not shown). In addition, ovariectomy did not modify plasma cholesterol levels. Based on other findings , we hypothesized that endogenous and/or genetic factors could be essential for the development of vascular senescence.
En face aorta images demonstrated that the localization of lipid deposition and vascular senescence in aged ApoE KO mice was mainly in the aortic arch, which is a turbulent flow area. This finding corroborates the hypothesis from others [42, 46, 49] that sites of high endothelial cell turnover associated with atherogenic stimuli can promote telomere shortening and possibly induction of senescence. We also could expect that oxidative stress and DNA damage contribute to vascular senescence (or vice-versa) and thus further promote atherogenesis.
In conclusion, both normocholesterolemic (C57) and hypercholesterolemic (ApoE KO) elderly mice exhibit aortic regurgitation, but it is of higher proportion in males than in females. The notable proportion of females with absence of aortic regurgitation leaves open the possibility of a gender-specific protection mechanism. On the other hand, vascular outward (positive) remodeling observed in hypercholesterolemic mice does not differ between the genders. Interesting that only vascular lipid deposition and senescence in elderly mice are influenced by both hypercholesterolemia and male gender, highlighting sex differences in the progression of vascular diseases in this important model of spontaneous atherosclerosis. Although further studies are needed to reveal the mechanisms underlying these findings, the present data provide significant progress in the understanding of gender-specific aspects influencing the development of cardiovascular diseases in order to improve prevention, diagnosis and develop appropriate interventions in elderly women and men.
This study was supported by the National Council for the Development of Science and Technology (CNPq), State Agency for the Development of Science and Technology (FAPES), and Funds for Science and Technology of the City of Vitoria (FACITEC). We are grateful to the University Hospital Cassiano Antonio de Moraes (HUCAM), Intercath-Meridional Hospital, Virchow Laboratory of Pathology and the Marcos Daniel Laboratory for use of their facilities.
- Forman DE, Cittadini A, Azhar G, Douglas PS, Wei JY: Cardiac Morphology and function in senescent rats: gender-related differences. J Am Coll Cardiol. 1997, 30: 1872-1877. 10.1016/S0735-1097(97)00411-7View ArticlePubMedGoogle Scholar
- Lakatta EG, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003, 107: 139-146. 10.1161/01.CIR.0000048892.83521.58View ArticlePubMedGoogle Scholar
- Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G, : Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006, 47 (3 Suppl): S4-S20. 10.1016/j.jacc.2005.01.072View ArticlePubMedGoogle Scholar
- McGrath KC, McRobb LS, Heather AK: Androgen therapy and atherosclerotic cardiovascular disease. Vasc Health Risk Manag. 2008, 4: 11-21. 10.2147/vhrm.2008.04.01.11PubMed CentralView ArticlePubMedGoogle Scholar
- Eckardstein A, Wu FC: Testosterone and atherosclerosis. Growth Horm IGF Res. 2003, 13 (suppl A): S72-84. 10.1016/S1096-6374(03)00059-5View ArticlePubMedGoogle Scholar
- Otto CM: Valvular heart disease: focus on women. Cardiol Rev. 2007, 15: 291-297. 10.1097/CRD.0b013e318156a798View ArticlePubMedGoogle Scholar
- Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Arch Med Res. 2007, 38: 816-821. 10.1016/j.arcmed.2007.06.005View ArticlePubMedGoogle Scholar
- Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R: Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007, 115: 377-386. 10.1161/CIRCULATIONAHA.106.654913View ArticlePubMedGoogle Scholar
- Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992, 71: 343-353. 10.1016/0092-8674(92)90362-GView ArticlePubMedGoogle Scholar
- Javień J, Nastalek P, Korbut R: Mouse models of experimental atherosclerosis. J Physiol Pharmacol. 2004, 55: 503-517.Google Scholar
- Arruda RM, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension. 2005, 46: 932-936. 10.1161/01.HYP.0000182154.61862.52View ArticlePubMedGoogle Scholar
- Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ: Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 1996, 93: 10022-10027. 10.1073/pnas.93.19.10022PubMed CentralView ArticlePubMedGoogle Scholar
- McRobb L, Handelsman DJ, Heather AK: Androgen-Induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology. 2009, 150: 841-848. 10.1210/en.2008-0760View ArticlePubMedGoogle Scholar
- Pujadas G: Coronary Angiography in the Medical and Surgical Treatment of Ischemic Heart Disease. 1980, New York: McGraw-Hill Book Company.Google Scholar
- Portes LA, Tucci PJ: Swim training attenuates myocardial remodeling and the pulmonary congestion in wistar rats with secondary heart failure to myocardial infarction. Arq Bras Cardiol. 2006, 87: 54-59. 10.1590/S0066-782X2006001400008View ArticlePubMedGoogle Scholar
- Minamino T, Yoshida T, Tateno K, Miyauchi H, Zou Y, Toko H, Komuro I: Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation. 2003, 108: 2264-2269. 10.1161/01.CIR.0000093274.82929.22View ArticlePubMedGoogle Scholar
- Droogmans S, Roosens B, Cosyns B, Hernot S, Weytjens C, Degaillier C, Garbar C, Caveliers V, Pipeleers-Marichal M, Franken PR, Bossuyt A, Lahoutte T, Schoors D, Van Camp G: Echocardiographic and histological assessment of age-related valvular changes in normal rats. Ultrasound Med Biol. 2009, 35: 558-565. 10.1016/j.ultrasmedbio.2008.10.006View ArticlePubMedGoogle Scholar
- Yamashita T, Kawashima S, Ozaki M, Namiki M, Hirase T, Inoue N, Hirata K, Umetani K, Sugimura K, Yokoyama M: Images in cardiovascular medicine. mouse coronary angiograph using synchrotron radiation microangiography. Circulation. 2002, 105: E3-4. 10.1161/hc0202.100423View ArticlePubMedGoogle Scholar
- Patten RD, Aronovitz MJ, Bridgman P, Pandian NG: Use of pulse wave and color flow Doppler echocardiography in mouse models of human disease. J Am Soc Echocardiogr. 2002, 15: 708-714. 10.1067/mje.2002.118912View ArticlePubMedGoogle Scholar
- Elangbam CS, Colman KA, Lightfoot RM, Tyler RD, Wall HG: Endocardial myxomatous change in Harlan Sprague-Dawley rats (Hsd:S-D) and CD-1 mice: its microscopic resemblance to drug-induced valvulopathy in humans. Toxicol Pathol. 2002, 30: 483-491.View ArticlePubMedGoogle Scholar
- Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, Takamoto S, Hirata Y, Nagai R: Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol. 2005, 46: 134-141. 10.1016/j.jacc.2005.03.058View ArticlePubMedGoogle Scholar
- Miller VM, Duckles SP: Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008, 60: 210-241. 10.1124/pr.107.08002PubMed CentralView ArticlePubMedGoogle Scholar
- Droogmans S, Franken PR, Garbar C, Weytjens C, Cosyns B, Lahoutte T, Caveliers V, Pipeleers-Marichal M, Bossuyt A, Schoors D, Van Camp G: In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology. Eur Heart J. 2007, 28: 2156-2162. 10.1093/eurheartj/ehm263View ArticlePubMedGoogle Scholar
- Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM, Kronzon I: The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med. 2002, 162: 2345-2347. 10.1001/archinte.162.20.2345View ArticlePubMedGoogle Scholar
- Hanada K, Vermeij M, Garinis GA, de Waard MC, Kunen MG, Myers L, Maas A, Duncker DJ, Meijers C, Dietz HC, Kanaar R, Essers J: Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ Res. 2007, 100: 738-746. 10.1161/01.RES.0000260181.19449.95View ArticlePubMedGoogle Scholar
- Nakanishi M, Harada M, Kishimoto I, Kuwahara K, Kawakami R, Nakagawa Y, Yasuno S, Usami S, Kinoshita H, Adachi Y, Fukamizu A, Saito Y, Nakao K: Genetic disruption of angiotensin II type 1a receptor improves long-term survival of mice with chronic severe aortic regurgitation. Circ J. 2007, 71: 1310-1316. 10.1253/circj.71.1310View ArticlePubMedGoogle Scholar
- Plante E, Lachance D, Gaudreau M, Drolet MC, Roussel E, Arsenault M, Couet J: Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation. 2004, 110: 1477-1483. 10.1161/01.CIR.0000141733.55236.9DView ArticlePubMedGoogle Scholar
- Xu Q, Ming Z, Dart AM, Du XJ: Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol. 2007, 34: 499-507. 10.1111/j.1440-1681.2007.04601.xView ArticlePubMedGoogle Scholar
- Droogmans S, Lauwers R, Cosyns B, Roosens B, Franken PR, Weytjens C, Bossuyt A, Lahoutte T, Schoors D, Van Camp G: Impact of anesthesia on valvular function in normal rats during echocardiography. Ultrasound Med Biol. 2008, 34: 1564-1572. 10.1016/j.ultrasmedbio.2008.02.017View ArticlePubMedGoogle Scholar
- Hart CY, Burnett JC, Redfield MM: Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am J Physiol Heart Circ Physiol. 2001, 281: H1938-1945.PubMedGoogle Scholar
- Kawaguchi A, Yutani C, Yamamoto A: Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis. Ther Apher Dial. 2003, 7: 439-443. 10.1046/j.1526-0968.2003.00075.xView ArticlePubMedGoogle Scholar
- Bekeredjian R, Grayburn PA: Valvular heart disease: aortic regurgitation. Circulation. 2005, 112: 125-134. 10.1161/CIRCULATIONAHA.104.488825View ArticlePubMedGoogle Scholar
- Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987, 316: 1371-1375. 10.1056/NEJM198705283162204View ArticlePubMedGoogle Scholar
- Langille BL: Arterial remodeling: relation to hemodynamics. Can J Physiol Pharmacol. 1996, 74: 834-841. 10.1139/cjpp-74-7-834View ArticlePubMedGoogle Scholar
- Lutgens E, de Muinck ED, Heeneman S, Daemen MJ: Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol. 2001, 21: 1359-1365. 10.1161/hq0801.093669View ArticlePubMedGoogle Scholar
- Meir KS, Leitersdorf E: Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol. 2004, 24: 1006-1014. 10.1161/01.ATV.0000128849.12617.f4View ArticlePubMedGoogle Scholar
- Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM: Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 1997, 17: 2333-2340.View ArticlePubMedGoogle Scholar
- Bentzon JF, Pasterkamp G, Falk E: Expansive remodeling is a response of the plaque-related vessel wall in aortic roots of apoE-deficient mice: an experiment of nature. Arterioscler Thromb Vasc Biol. 2003, 23: 257-262. 10.1161/01.ATV.0000051387.70962.79View ArticlePubMedGoogle Scholar
- Glagov S, Ko C, Bassiouny HS, Zarins CK: Principles of vascular remodeling. Panvascular Medicine. Edited by: Lanzer P, Topol EJ. 2002, 232-241. Berlin: Springer-Verlag.Google Scholar
- Pasterkamp G, Smits PC: Imaging of atherosclerosis. Remodelling of coronary arteries. J Cardiovasc Risk. 2002, 9: 229-235. 10.1097/00043798-200210000-00002View ArticlePubMedGoogle Scholar
- Kunieda T, Minamino T, Nishi J, Tateno K, Oyama T, Katsuno T, Miyauchi H, Orimo M, Okada S, Takamura M, Nagai T, Kaneko S, Komuro I: Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation. 2006, 114: 953-960. 10.1161/CIRCULATIONAHA.106.626606View ArticlePubMedGoogle Scholar
- Minamino T, Komuro I: Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007, 100: 15-26. 10.1161/01.RES.0000256837.40544.4aView ArticlePubMedGoogle Scholar
- Nakajima M, Hashimoto M, Wang F, Yamanaga K, Nakamura N, Uchida T, Yamanouchi K: Aging decreases the production of PGI2 in rat aortic endothelial cells. Exp Gerontol. 1997, 32: 685-693. 10.1016/S0531-5565(97)00089-2View ArticlePubMedGoogle Scholar
- Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS: eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res. 2001, 89: 793-798. 10.1161/hh2101.098443View ArticlePubMedGoogle Scholar
- Chang E, Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 1995, 92: 11190-11194. 10.1073/pnas.92.24.11190PubMed CentralView ArticlePubMedGoogle Scholar
- Erusalimsky JD, Kurz DJ: Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol. 2005, 40: 634-642. 10.1016/j.exger.2005.04.010View ArticlePubMedGoogle Scholar
- Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, Asai J, Tsutsumi Y, Sekiguchi H, Silver M, Wecker A, Bord E, Zhu Y, Kishore R, Losordo DW: Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 2006, 114: 2261-2270. 10.1161/CIRCULATIONAHA.106.631465View ArticlePubMedGoogle Scholar
- Nawrot TS, Staessen JA, Gardner JP, Aviv A: Telomere length and possible link to X chromosome. Lancet. 2004, 363: 507-510. 10.1016/S0140-6736(04)15535-9View ArticlePubMedGoogle Scholar
- Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, Goddard M, Bennett M: Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res. 2006, 99: 156-164. 10.1161/01.RES.0000233315.38086.bcView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.